Low-dose prolonged intermittent interleukin-2 adjuvant therapy: results of a randomized trial among human immunodeficiency virus-positive patients with advanced immune impairment.

Giulia Marchetti; Luca Meroni; Stefania Varchetta; Velislava Terzieva; Alessandra Bandera; Daniele Manganaro; Chiara Molteni; Daria Trabattoni; Sabrina Fossati; Mario Clerici

doi:10.1086/342479

Low-dose prolonged intermittent interleukin-2 adjuvant therapy: results of a randomized trial among human immunodeficiency virus-positive patients with advanced immune impairment.

Identifier:nobleid.org/w1/20260515/DFFFCCD4

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/DFFFCCD4.svg?ark=w1%2F20260515%2FDFFFCCD4)](https://nobleid.org/work/w1/20260515/DFFFCCD4)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Low-dose prolonged intermittent interleukin-2 adjuvant therapy: results of a randomized trial among human immunodeficiency virus-positive patients with advanced immune impairment.

Identifier:nobleid.org/w1/20260515/DFFFCCD4

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/DFFFCCD4.svg?ark=w1%2F20260515%2FDFFFCCD4)](https://nobleid.org/work/w1/20260515/DFFFCCD4)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work